ID: uc002ddd.7
GENE: NTAN1(2)
chr16:15141728-15141903-


(1)
AGO2.ip
(2)
B-CELL
(1)
BREAST
(9)
CELL-LINE
(2)
CERVIX
(1)
HELA
(2)
LIVER
(1)
OTHER
(9)
SKIN

Sense strand
CCTTCTGTATGTTCAGCAAAGAGAGCTTGCAGTGACCTCCCCAAAGGATGGTAGGTTAGGAAGCAGTGAATTGGGCGTTATCCCAAAAGGCTATTGGATATTTTATTTTATTTCTTTTTTAAACAGGCTCCATCTCCATTCTGGGTTCTGATGATGCCACTACTTGTCACATTGTG
......................................................(((((((((.((((((.((((...(((((............))))).)))).)))))).))))))..)))....................................................
..................................................51.........................................................................126................................................
SizePerfect hitTotal NormPerfect NormSRR189780(GSM714640)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR207116(GSM721078)
Nuclear RNA. (cell line)
SRR330896(SRX091734)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR189778(GSM714638)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR330921(SRX091759)
tissue: normal skindisease state: normal. (skin)
RoviraIPAgo2(Rovira)
total RNA. (ago2 breast)
SRR444061(SRX128909)
Sample 19cDNABarcode: AF-PP-341: ACG CTC TTC . (skin)
SRR039616(GSM531979)
HBV(+) Distal Tissue Sample 1. (liver)
SRR189784SRR039621(GSM531984)
HBV(+) HCC Tissue Sample 2. (liver)
SRR189775(GSM714635)
cell line: HEK293clip variant: CLIPenzymatic . (cell line)
SRR033722(GSM497067)
KMS12 cell line (KMS12). (B cell)
SRR330863(SRX091701)
tissue: skin psoriatic involveddisease state:. (skin)
GSM532874(GSM532874)
G699T. (cervix)
SRR330897(SRX091735)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR040008(GSM532893)
G727N. (cervix)
SRR033727(GSM497072)
HIV-positive DL (HIV412). (B cell)
SRR189779(GSM714639)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR330858(SRX091696)
tissue: skin psoriatic involveddisease state:. (skin)
SRR330902(SRX091740)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR189776(GSM714636)
cell line: HEK293clip variant: CLIPenzymatic . (cell line)
DRR001488(DRX001042)
"Hela short nuclear cell fraction, LNA(+)". (hela)
DRR000556(DRX000314)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)
GSM416733(GSM416733)
HEK293. (cell line)
SRR330911(SRX091749)
tissue: normal skindisease state: normal. (skin)
SRR037931(GSM510469)
293GFP. (cell line)
SRR330878(SRX091716)
tissue: skin psoriatic involveddisease state:. (skin)
...TCTGTATGTTCAGCAAAGAGAGCTTGCAGTG..............................................................................................................................................3112.002.00--2.00------------------------
..................................................................................................TATTTTATTTTATTTCTTTGCAG.......................................................232.000.002.00--------------------------
............................................................................................................................................CTGGGTTCTGATGATGCCA.................1911.001.00---------------1.00-----------
..........................................AAAGGATGGTAGGTTAGGAAGCAG..............................................................................................................2411.001.00-------------------1.00-------
............................................................................................ATTGGATATTTTATTTTAGGGG..............................................................221.000.00-1.00-------------------------
..................................................................................................TATTTTATTTTATTTCTTTTAAGC......................................................241.000.001.00--------------------------
...........................................................................................................................................TCTGGGTTCTGATGATGC...................1811.001.00-------1.00-------------------
...................................................................................................ATTTTATTTTATTTCTTCAG.........................................................201.000.00---1.00-----------------------
..............................................................................................TGGATATTTTATTTTTGGC...............................................................191.000.001.00--------------------------
...................................................................................................ATTTTATTTTATTTCTTTCAAG.......................................................221.000.00--------------------1.00------
..................AAGAGAGCTTGCAGTGACCTCCCCAAAGGATGGC............................................................................................................................341.000.00-----1.00---------------------
............................................................................................ATTGGATATTTTATTTTAGGG...............................................................211.000.00-1.00-------------------------
..............................................................................................TGGATATTTTATTTTATTTCTGGC..........................................................241.000.00-----------------1.00---------
.........................................................................................................................................ATTCTGGGTTCTGATGATGCC..................2111.001.00-------------1.00-------------
............................................................................................ATTGGATATTTTATTTTAGTTA..............................................................221.000.00-1.00-------------------------
..........................................................................................................TTTATTTCTTTTTTAACTAG..................................................201.000.00----------1.00----------------
..................................................GTAGGTTAGGAAGCAGTGAATTGGG.....................................................................................................2511.001.00-----------1.00---------------
....................................................................................................TTTTATTTTATTTCTTTTTGGAG.....................................................231.000.001.00--------------------------
.................................................................................................ATATTTTATTTTATTTCTTTATG........................................................231.000.00---1.00-----------------------

Antisense strand
CCTTCTGTATGTTCAGCAAAGAGAGCTTGCAGTGACCTCCCCAAAGGATGGTAGGTTAGGAAGCAGTGAATTGGGCGTTATCCCAAAAGGCTATTGGATATTTTATTTTATTTCTTTTTTAAACAGGCTCCATCTCCATTCTGGGTTCTGATGATGCCACTACTTGTCACATTGTG
......................................................(((((((((.((((((.((((...(((((............))))).)))).)))))).))))))..)))....................................................
..................................................51.........................................................................126................................................
SizePerfect hitTotal NormPerfect NormSRR189780(GSM714640)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR207116(GSM721078)
Nuclear RNA. (cell line)
SRR330896(SRX091734)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR189778(GSM714638)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR330921(SRX091759)
tissue: normal skindisease state: normal. (skin)
RoviraIPAgo2(Rovira)
total RNA. (ago2 breast)
SRR444061(SRX128909)
Sample 19cDNABarcode: AF-PP-341: ACG CTC TTC . (skin)
SRR039616(GSM531979)
HBV(+) Distal Tissue Sample 1. (liver)
SRR189784SRR039621(GSM531984)
HBV(+) HCC Tissue Sample 2. (liver)
SRR189775(GSM714635)
cell line: HEK293clip variant: CLIPenzymatic . (cell line)
SRR033722(GSM497067)
KMS12 cell line (KMS12). (B cell)
SRR330863(SRX091701)
tissue: skin psoriatic involveddisease state:. (skin)
GSM532874(GSM532874)
G699T. (cervix)
SRR330897(SRX091735)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR040008(GSM532893)
G727N. (cervix)
SRR033727(GSM497072)
HIV-positive DL (HIV412). (B cell)
SRR189779(GSM714639)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR330858(SRX091696)
tissue: skin psoriatic involveddisease state:. (skin)
SRR330902(SRX091740)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR189776(GSM714636)
cell line: HEK293clip variant: CLIPenzymatic . (cell line)
DRR001488(DRX001042)
"Hela short nuclear cell fraction, LNA(+)". (hela)
DRR000556(DRX000314)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)
GSM416733(GSM416733)
HEK293. (cell line)
SRR330911(SRX091749)
tissue: normal skindisease state: normal. (skin)
SRR037931(GSM510469)
293GFP. (cell line)
SRR330878(SRX091716)
tissue: skin psoriatic involveddisease state:. (skin)
..........................................................................................................................CAGAATGGAGATGGAGCCTGT................................. 2111.001.00------------1.00--------------
.........................TTGGGGAGGTCACTGCAAG.................................................................................................................................... 1911.001.00----------------1.00----------
.............................CAGTGACCTCCCCAAAGTTAG.............................................................................................................................. 211.000.00------1.00--------------------
.......................................................................................................................................................ACAATGTGACAAGTAGTGGCATCA. 2411.001.00---------1.00-----------------
...........................................................................................................................CAGGCTCCATCTCCAAGA................................... 181.000.00--------------1.00------------
...........................................................................................................................AACCCAGAATGGAGATGGAGCCTG............................. 2411.001.00----1.00----------------------
.....................................................................................................TTTATTTTATTTCTTTTGAGG...................................................... 211.000.00--------1.00------------------
..........................................................................................................................................TTCTGGGTTCTGATGAAGG................... 191.000.00------------------1.00--------
.................................GACCTCCCCAAAGGACTTA............................................................................................................................ 190.500.00--0.12------------------0.12-0.12-0.12-
.CTTTGCTGAACATACAGAAG........................................................................................................................................................... 2020.500.50----0.50----------------------
.................................TCCTTTGGGGAGGTC................................................................................................................................ 1580.250.25---------------------0.120.12----
.................................GACCTCCCCAAAGGAC............................................................................................................................... 160.250.00---------------------0.25-----
.................................GACCTCCCCAAAGGACTT............................................................................................................................. 180.120.00------------------------0.12--
.................................GACCTCCCCAAAGGACT.............................................................................................................................. 170.120.00--------------------------0.12